Literature DB >> 33687713

Human Blood Plasma Investigation Employing 2D UPLC-UDMSE Data-Independent Acquisition Proteomics.

Licia C Silva-Costa1, Bradley J Smith1, Pamela T Carlson1, Gustavo H M F Souza2, Daniel Martins-de-Souza3,4,5,6.   

Abstract

Proteomic tools are especially useful when it comes to investigating complex samples such as human blood plasma, in which protein quantities can span across up to ten orders of magnitude. Ultra definition mass spectrometry, in combination with two-dimensional liquid chromatography, provides better coverage of complex proteomes and allows for better control of collision energy, keeping the fragmentation benefits of high collision energy associated with drift time measurements from ion mobility separation. Here, we present a protocol to assist in the identification of proteins in human blood plasma and other similar samples with a large dynamic range.

Entities:  

Keywords:  Depletion; Immunoaffinity depletion; Mass spectrometry; Multifactorial disorders; Serum; Tryptic digestion

Mesh:

Substances:

Year:  2021        PMID: 33687713     DOI: 10.1007/978-1-0716-1178-4_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

Review 1.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

Review 2.  Shotgun proteomics: tools for the analysis of complex biological systems.

Authors:  Christine C Wu; Michael J MacCoss
Journal:  Curr Opin Mol Ther       Date:  2002-06

3.  The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins.

Authors:  Rembert Pieper; Christine L Gatlin; Anthony J Makusky; Paul S Russo; Courtney R Schatz; Stanton S Miller; Qin Su; Andrew M McGrath; Marla A Estock; Prashanth P Parmar; Ming Zhao; Shih-Ting Huang; Jeff Zhou; Fang Wang; Ricardo Esquer-Blasco; N Leigh Anderson; John Taylor; Sandra Steiner
Journal:  Proteomics       Date:  2003-07       Impact factor: 3.984

4.  Characterization of the low molecular weight human serum proteome.

Authors:  Radhakrishna S Tirumalai; King C Chan; DaRue A Prieto; Haleem J Issaq; Thomas P Conrads; Timothy D Veenstra
Journal:  Mol Cell Proteomics       Date:  2003-08-13       Impact factor: 5.911

Review 5.  Mass-spectrometric exploration of proteome structure and function.

Authors:  Ruedi Aebersold; Matthias Mann
Journal:  Nature       Date:  2016-09-15       Impact factor: 49.962

6.  Multifactorial disease risk calculator: Risk prediction for multifactorial disease pedigrees.

Authors:  Desmond D Campbell; Yiming Li; Pak C Sham
Journal:  Genet Epidemiol       Date:  2017-11-26       Impact factor: 2.135

7.  The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays.

Authors:  Jochen M Schwenk; Gilbert S Omenn; Zhi Sun; David S Campbell; Mark S Baker; Christopher M Overall; Ruedi Aebersold; Robert L Moritz; Eric W Deutsch
Journal:  J Proteome Res       Date:  2017-10-10       Impact factor: 4.466

Review 8.  The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine.

Authors:  Francesca L Guest; Paul C Guest; Daniel Martins-de-Souza
Journal:  Biomark Med       Date:  2016-03-21       Impact factor: 2.851

Review 9.  Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.

Authors:  Suman Patel
Journal:  Adv Protein Chem Struct Biol       Date:  2014       Impact factor: 3.507

10.  Enabling point-of-care testing and personalized medicine for schizophrenia.

Authors:  Paul C Guest; Daniel Martins-de-Souza
Journal:  NPJ Schizophr       Date:  2017-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.